Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Interaction of Agouti protein with the melanocortin 1 receptor in vitro and in vivo.

Ollmann MM, Lamoreux ML, Wilson BD, Barsh GS.

Genes Dev. 1998 Feb 1;12(3):316-30.

2.

Molecular pharmacology of Agouti protein in vitro and in vivo.

Barsh GS, Ollmann MM, Wilson BD, Miller KA, Gunn TM.

Ann N Y Acad Sci. 1999 Oct 20;885:143-52. Review.

PMID:
10816647
3.

The melanocortin-1 receptor and human pigmentation.

Abdel-Malek Z, Suzuki I, Tada A, Im S, Akcali C.

Ann N Y Acad Sci. 1999 Oct 20;885:117-33. Review.

PMID:
10816645
4.

Melanocortin receptors and antagonists regulate pigmentation and body weight.

Jordan SA, Jackson IJ.

Bioessays. 1998 Aug;20(8):603-6. Review.

PMID:
9780833
5.

Significance of the melanocortin 1 receptor in regulating human melanocyte pigmentation, proliferation, and survival.

Kadekaro AL, Kanto H, Kavanagh R, Abdel-Malek Z.

Ann N Y Acad Sci. 2003 Jun;994:359-65. Review.

PMID:
12851336
6.

Agouti: from mouse to man, from skin to fat.

Voisey J, van Daal A.

Pigment Cell Res. 2002 Feb;15(1):10-8. Review.

PMID:
11837451
7.

Melanocortins and their receptors and antagonists.

Voisey J, Carroll L, van Daal A.

Curr Drug Targets. 2003 Oct;4(7):586-97. Review.

PMID:
14535656
8.

The melanocortin receptors: agonists, antagonists, and the hormonal control of pigmentation.

Cone RD, Lu D, Koppula S, Vage DI, Klungland H, Boston B, Chen W, Orth DN, Pouton C, Kesterson RA.

Recent Prog Horm Res. 1996;51:287-317; discussion 318. Review.

PMID:
8701084
9.

Inverse agonism gains weight.

Adan RA, Kas MJ.

Trends Pharmacol Sci. 2003 Jun;24(6):315-21. Review.

PMID:
12823958
10.

alpha-MSH and desacetyl-alpha-MSH signaling through melanocortin receptors.

Mountjoy KG, Wu CS, Cornish J, Callon KE.

Ann N Y Acad Sci. 2003 Jun;994:58-65. Review.

PMID:
12851298
11.

The yellow mouse obesity syndrome and mechanisms of agouti-induced obesity.

Moussa NM, Claycombe KJ.

Obes Res. 1999 Sep;7(5):506-14. Review.

12.

The role of the agouti gene in the yellow obese syndrome.

Miltenberger RJ, Mynatt RL, Wilkinson JE, Woychik RP.

J Nutr. 1997 Sep;127(9):1902S-1907S. Review.

13.

Engineering the melanocortin-4 receptor to control G(s) signaling in vivo.

Srinivasan S, Vaisse C, Conklin BR.

Ann N Y Acad Sci. 2003 Jun;994:225-32. Review.

PMID:
12851320
14.

Regulation of the mesocorticolimbic and mesostriatal dopamine systems by α-melanocyte stimulating hormone and agouti-related protein.

Roseberry AG, Stuhrman K, Dunigan AI.

Neurosci Biobehav Rev. 2015 Sep;56:15-25. doi: 10.1016/j.neubiorev.2015.06.020. Epub 2015 Jun 24. Review.

PMID:
26116876
15.

Studies on the physiological functions of the melanocortin system.

Cone RD.

Endocr Rev. 2006 Dec;27(7):736-49. Epub 2006 Oct 31. Review.

PMID:
17077189
16.

Participation of the melanocortin-1 receptor in the UV control of pigmentation.

Suzuki I, Im S, Tada A, Scott C, Akcali C, Davis MB, Barsh G, Hearing V, Abdel-Malek Z.

J Investig Dermatol Symp Proc. 1999 Sep;4(1):29-34. Review.

17.

New aspects on the melanocortins and their receptors.

Wikberg JE, Muceniece R, Mandrika I, Prusis P, Lindblom J, Post C, Skottner A.

Pharmacol Res. 2000 Nov;42(5):393-420. Review.

PMID:
11023702
18.

Evolution of the melanocortin system.

Cortés R, Navarro S, Agulleiro MJ, Guillot R, García-Herranz V, Sánchez E, Cerdá-Reverter JM.

Gen Comp Endocrinol. 2014 Dec 1;209:3-10. doi: 10.1016/j.ygcen.2014.04.005. Epub 2014 Apr 21. Review.

PMID:
24768673
19.

Melanocortin receptor ligands: new horizons for skin biology and clinical dermatology.

Böhm M, Luger TA, Tobin DJ, García-Borrón JC.

J Invest Dermatol. 2006 Sep;126(9):1966-75. Review.

20.

Melanocortin receptors: their functions and regulation by physiological agonists and antagonists.

Abdel-Malek ZA.

Cell Mol Life Sci. 2001 Mar;58(3):434-41. Review.

PMID:
11315190
Items per page

Supplemental Content

Write to the Help Desk